EXPLORE!

H Pylori new treatment consensus

  32062 Views

Dr KK Aggarwal    05 September 2018

American College of Gastroenterology Clinical Guideline

Antibiotic Selection

There is increased resistance to clarithromycin, and traditional triple therapy (clarithromycin + amoxicillin + proton pump inhibitors [PPIs]) should not be prescribed unless the rates of clarithromycin resistance are known to be < 15%.

We should not use clarithromycin triple therapy.

Then what to use as First-Line Therapy

Quadruple therapy: Clarithromycin (500 mg), amoxicillin (1 g), metronidazole (500 mg), and a PPI, all given twice a day.

Or bismuth subsalicylate (2 tablets four times a day), metronidazole (500 mg three or four times a day), tetracycline (500 mg four times a day), and a PPI (twice a day). Patients on this regimen will need to be informed about bismuth-related stool darkening.

Or Triple therapy with levofloxacin (500 mg once a day), amoxicillin (1 g twice a day), and a PPI (twice a day) is an alternative but not recommended as the best initial option.

Treatment Duration

Recommendation is 14 days

Salvage Therapy for Persistent H pylori Infection

Avoid antibiotics previously used

Bismuth-based quadruple therapy or levofloxacin triple therapy are accepted salvage regimens.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.